OC-0270: QoL and toxicity of HDR prostate brachytherapy as monotherapy 19Gy single fraction:phase II trial
Gomez-Iturriaga, A., Casquero, F., Minguez, P., Espinosa, J., Bueso, A., Cacicedo, J., Fernandez, L., Pedraza, S., Garcia Escovedo, J., Bilbao, P.Volume:
123
Language:
english
Journal:
Radiotherapy and Oncology
DOI:
10.1016/s0167-8140(17)30713-2
Date:
May, 2017
File:
PDF, 201 KB
english, 2017